Kyron.bio

We have made giant leaps in drug discovery over the past 5 years, however the bioproduction industry cannot keep up. kyron.bio’s mission is to revolutionise therapeutic protein production. Our Next Generation Bioproduction Platform boosts both the effectiveness and yield of proteins produced in mammalian cells. We are doing this by harnessing highly efficient processes from diverse organisms to genetically engineer the drug production platform of the future.

Our vision is to make the production of therapeutic proteins cheaper, more effective and less wasteful.

We are backed by Entrepreneur First, the world’s leading talent investor, along with both European and US investors. We have partnerships with the Danish Technical University and the University of Dundee, and are advised by senior VPs at Sanofi and GSK.